Annual Shareholders Equity
$16.77 M
-$99.23 M-85.55%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual stockholders equity is $16.77 million, with the most recent change of -$99.23 million (-85.55%) on December 31, 2023.
- During the last 3 years, MRNS annual shareholders equity has fallen by -$120.43 million (-87.78%).
- MRNS annual shareholders equity is now -87.78% below its all-time high of $137.20 million, reached on December 31, 2020.
Performance
MRNS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$66.74 M
-$19.39 M-40.97%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly stockholders equity is -$66.74 million, with the most recent change of -$19.39 million (-40.97%) on September 30, 2024.
- Over the past year, MRNS quarterly shareholders equity has stayed the same.
- MRNS quarterly shareholders equity is now -148.64% below its all-time high of $137.20 million, reached on December 31, 2020.
Performance
MRNS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MRNS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.5% | 0.0% |
| 3 y3 years | -87.8% | -157.5% |
| 5 y5 years | -75.5% | -157.5% |
MRNS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.5% | at low | -157.5% | at low |
| 5 y | 5-year | -87.8% | at low | -148.6% | at low |
| alltime | all time | -87.8% | +300.9% | -148.6% | at low |
Marinus Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$66.74 M(+41.0%) |
| Jun 2024 | - | -$47.34 M(+188.1%) |
| Mar 2024 | - | -$16.43 M(-198.0%) |
| Dec 2023 | $16.77 M(-85.5%) | $16.77 M(-69.3%) |
| Sep 2023 | - | $54.54 M(-4.9%) |
| Jun 2023 | - | $57.34 M(-32.6%) |
| Mar 2023 | - | $85.08 M(-26.7%) |
| Dec 2022 | $116.00 M(+116.9%) | $116.00 M(+41.5%) |
| Sep 2022 | - | $82.00 M(+1607.3%) |
| Jun 2022 | - | $4.80 M(-88.1%) |
| Mar 2022 | - | $40.41 M(-24.5%) |
| Dec 2021 | $53.49 M(-61.0%) | $53.49 M(-31.9%) |
| Sep 2021 | - | $78.49 M(-17.4%) |
| Jun 2021 | - | $95.06 M(-17.6%) |
| Mar 2021 | - | $115.33 M(-15.9%) |
| Dec 2020 | $137.20 M(+56.3%) | $137.20 M(+56.9%) |
| Sep 2020 | - | $87.42 M(-13.6%) |
| Jun 2020 | - | $101.14 M(+41.8%) |
| Mar 2020 | - | $71.31 M(-18.7%) |
| Dec 2019 | $87.77 M | $87.77 M(+157.6%) |
| Sep 2019 | - | $34.07 M(-26.9%) |
| Jun 2019 | - | $46.59 M(-19.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $57.74 M(-15.5%) |
| Dec 2018 | $68.33 M(+17.8%) | $68.33 M(+94.5%) |
| Sep 2018 | - | $35.12 M(-22.0%) |
| Jun 2018 | - | $45.02 M(-15.3%) |
| Mar 2018 | - | $53.13 M(-8.4%) |
| Dec 2017 | $58.01 M(+170.1%) | $58.01 M(-6.6%) |
| Sep 2017 | - | $62.10 M(+281.2%) |
| Jun 2017 | - | $16.29 M(-15.4%) |
| Mar 2017 | - | $19.25 M(-10.4%) |
| Dec 2016 | $21.48 M(-54.2%) | $21.48 M(-19.5%) |
| Sep 2016 | - | $26.69 M(-17.4%) |
| Jun 2016 | - | $32.33 M(-20.3%) |
| Mar 2016 | - | $40.57 M(-13.5%) |
| Dec 2015 | $46.92 M(+14.0%) | $46.92 M(+82.9%) |
| Sep 2015 | - | $25.66 M(-14.1%) |
| Jun 2015 | - | $29.88 M(-14.0%) |
| Mar 2015 | - | $34.73 M(-15.6%) |
| Dec 2014 | $41.15 M(+335.1%) | $41.15 M(-6.9%) |
| Sep 2014 | - | $44.23 M(+888.1%) |
| Jun 2014 | - | $4.48 M(-47.6%) |
| Mar 2014 | - | $8.54 M(-9.7%) |
| Dec 2013 | $9.46 M(+126.1%) | $9.46 M |
| Dec 2012 | $4.18 M | - |
FAQ
- What is Marinus Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual shareholders equity year-on-year change?
- What is Marinus Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Marinus Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of MRNS is $16.77 M
What is the all time high annual shareholders equity for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual stockholders equity is $137.20 M
What is Marinus Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, MRNS annual stockholders equity has changed by -$99.23 M (-85.55%)
What is Marinus Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of MRNS is -$66.74 M
What is the all time high quarterly shareholders equity for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly stockholders equity is $137.20 M
What is Marinus Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, MRNS quarterly stockholders equity has changed by $0.00 (0.00%)